Autism Gene Therapy Trial Reaches Patients as US Primate Labs Cede Ground to China

0 points · first seen 23h ago · 1 outlet · 0 comments

Autism gene therapy trial JAG201 is enrolling children ages 2-9 with confirmed SHANK3 gene mutations at US medical centers -- the same macaque primate research infrastructure that enabled JAG201's development is now being dismantled under DOGE pressure, as China commits $743 million to build competing primate neuroscience labs. — Tech Times

save

· share to X · Bluesky · copy link